Abstract
Introduction

54
Corneal transparency is critical for good visual acuity. The corneal endothelium regulates the 55 hydration status of the cornea and has an essential role in maintaining corneal deturgescence and 56 preventing edema that can degrade corneal transparency. It is the innermost layer of the cornea 57 and is composed of a single layer of cells that pump excess fluid out of the cornea through active 58 ion-transport processes [1, 2] . 59
Fuchs endothelial corneal dystrophy (FECD) is a bilateral, slowly progressive disorder in 60 which the corneal endothelial cells are diseased and become less efficient at removing fluid. As a 61 result, the highly ordered arrangement of collagen fibers in the corneal stromal layer become 62 disrupted, leading to corneal opacification and vision loss [3] . Other clinical phenotypic changes 63 cataract [29] . Epigenetic factors may help explain the phenotypic variation seen amongst cohorts 87 with identical genotypes, including in FECD. We previously identified DNA methylation changes 88 that occur in the corneal endothelial tissue of patients with late-onset FECD using a genome-wide 89 DNA methylation array [30] . Furthermore, many of these changes occurred in microRNA (miRNA) 90 sequences [30] . 91
Multiple studies over the past decade have demonstrated that miRNAs profoundly 92 influence the cellular responses of tissues to physiologic and pathophysiologic stresses in multiple 93 disease states [31, 32] . Stress-dependent regulation can involve upregulation or downregulation of 94 miRNA expression and lead to downstream signaling effects on mRNA targets [31] . Accumulating 95 evidence from human and animal studies have shown that DNA methylation-associated silencing 96 of miRNAs contributes to disease pathogenesis [33] . In the present study, we further analyzed the 97 subset of miRNA data to test the hypothesis that aberrant DNA methylation of miRNAs 98 contributes to FECD pathogenesis. We found that the majority of differentially methylated 99 miRNAs display promoter DNA hypermethylation in FECD. Moreover, we identified miR-199B 100 to be extensively hypermethylated in FECD. Using in silico and functional assays, we determined 101 that miR-199b-5p directly targets and negatively regulates the expression of two key transcription 102 factors that control ECM production in FECD. Taken together, these findings demonstrate a novel 103 mechanism of epigenetic regulation of ECM production in FECD pathogenesis and identifies miR-104 199b-5p as a potential clinical biomarker of disease. 105
106
Results
107
Global DNA methylation patterns of miRNA sequences are altered in FECD 108
Our prior genome-scale analysis of the DNA methylation landscape of corneal endothelial tissue 109 found a significant difference between FECD and normal control patients [30] . In particular, we 110 identified a high number of differentially methylated miRNA sequences [30] . Because DNA 111 methylation plays a central role in regulating miRNA expression [34, 35] and widespread miRNA 112 downregulation has been observed in FECD [36] , we performed a subanalysis of the Illumina 113 Infinium HumanMethylation450 (HM450) array data to focus on the 2,227 miRNA probes 114 (targeting 463 miRNA genes in total). Sample pairwise correlation and hierarchical clustering 115 analyses revealed differential genome-wide miRNA DNA methylation patterns in FECD samples 116 compared with normal control samples (Fig 1) . Further nonparametric principle component 117 analyses showed that this variance was not attributable to the clinical variables of age, sex, 118 pachymetry, or guttata grading (data not shown). 119
120
The majority of differentially methylated miRNAs display promoter DNA hypermethylation 121
in FECD 122
We next examined and compared the DNA methylation levels of individual miRNA sequences 123 between FECD cases and controls by comparing single HM450 probes. Of the 2,227 miRNA-124 associated probes (targeting 463 miRNA genes), 216 probes (targeting 156 miRNA genes) were 125 differentially methylated in the FECD samples (P < 0.05; Fig 2A) . Of the 216 probes, the large 126 majority (154 probes; 71%) were hypermethylated in the FECD samples, and a small minority (62 127 probes; 29%) of sequences were hypomethylated (Fig 2B) . Almost all of the differentially 128 methylated probes (208 probes; 96%) targeted miRNA promoter sequences (148/154 129 hypermethylated probes and 60/62 hypomethylated probes; Fig 2B) . None of the miRNA probes 130
were significantly differentially methylated with respect to age or sex, suggesting that these 131 parameters are not major drivers of DNA methylation changes in miRNA genes in FECD patients 132 (data not shown). Table 1 shows details on the 20 top ranking differentially methylated miRNA 133 genes in the FECD samples as compared to controls. miR199-B was found to be the most 134 hypermethylated miRNA gene and miR-1182 was the most hypomethylated miRNA gene in FECD 135 samples (Table 1) . 136
137
Genomic locations of differentially methylated miRNA genes with respect to their host genes 138
The majority of miRNAs are located within intronic or exonic regions of protein-coding genes 139 (host genes), and increasing evidence suggests a functional relationship between miRNAs and 140 their host genes [37] . Therefore, we next sought to examine the spatial relationship of the 141 differentially methylated miRNA probes with their host genes. We mapped all 216 differentially 142 methylated miRNA probes to their host genes using the Ensembl Genome Browser 143 (https://uswest.ensembl.org/index.html). Of the 154 hypermethylated miRNA probes, 74% (113 144 probes) corresponded to intragenic sequences and 27% (41 probes) occurred in intergenic 145 sequences (Fig 2C) . Of the intragenic probes, 41% (63 probes) occurred within intronic sequences, 146 23% (36 probes) within exonic sequences, and 9% (14 probes) in intron/exon boundaries ( Fig 2C) . 147 Similar to the hypermethylated probes, the majority of hypomethylated miRNA probes occurred 148 in intragenic sequences (71%, 44 out of 62 probes) and intronic sequences (44% intronic, 24% 149 exonic, 3% in intron/exon boundary sequences) (Fig 2D) . Together, these data show that the 150 majority of differentially methylated miRNA probes occur in intragenic and intronic sequences of 151 their host genes. Our prior genome-scale analysis of the DNA methylation landscape of corneal 152 endothelial tissue found a significant difference between FECD and normal control patients [30] . 153 154 Gene body regions of miRNA host genes are frequent targets of aberrant DNA methylation 155
in FECD 156
Emerging evidence has revealed mutually regulatory roles between particular miRNAs and their 157 host genes [38] [39] [40] [41] . Therefore, to decipher the function of DNA methylation in the epigenetic 158 regulation of miRNAs and their host genes, we next assessed the methylation status of host genes 159 for the 156 differentially methylation miRNA genes in FECD. The list of 156 host genes was 160 curated using publicly available miRNA databases, including Ensembl Genome Browser 161 (https://uswest.ensembl.org/index.html), miRIAD (http://www.miriad-database.org), and 162 miRStart (http://mirstart.mbc.nctu.edu.tw/about.php). A total of 1,823 probes mapped to CpG sites 163 in the set of 156 host genes. A volcano plot display of the DNA methylation status of the 1,823 164 probes showed that 239 probes were differentially methylated in FECD samples compared to 165 control samples (P < 0.05; Fig 3A) . In fact, most (188; 79%) of the 239 differentially methylated 166
CpG sites were hypermethylated in FECD samples, with only a minority (51; 21%) of them 167 hypomethylated. Alignment of the probe sequences to the human genome database revealed that 168 the vast majority (192; 80%) of the 239 differentially methylated CpG sites were located in the 169 gene body regions of miRNA host genes (Fig 3B) . A substantial proportion (161; 86%) of the 188 170 hypermethylated probes targeted CpG sites within gene bodies, whereas only 14% of them were 171 mapped to the promoter regions of corresponding miRNA host genes. Similarly, a high percentage 172 (31; 61%) of the 51 hypomethylated probes also mapped to gene body sequences of miRNA host 173 genes. Table 2 provides detailed information on the top 20 differentially methylated miRNA host 174 genes identified in the FECD samples as compared to controls. Given that miRNAs may be co-175 regulated with their host genes, we further analyzed the DNA methylation data for co-methylation 176 patterns. We identified a subset of miRNAs and their host genes to be co-methylated at their 177 corresponding promoter CpG sites, suggesting that DNA methylation may play an important role 178 in regulating the co-expression of miRNAs and their host genes in FECD (Fig 3C) miR-199A1, miR-874, miR-140, miR-23B, and miR-1306 (Fig S1, Table S1 ). 185
These miRNAs were selected for validation because of their important roles in the pathogenesis 186 of FECD or in the regulation of key cellular processes (e.g. cell survival, oxidative stress, 187 inflammation, fibrosis, and deposition of extracellular matrix) [43] [44] [45] [46] [47] [48] [49] [50] . The MethyLight results 188 confirmed DNA hypermethylation in the FECD samples compared with control samples (Fig 4) (Fig 5A, B) . In particular, miR-199b-5p expression was almost completely silenced [36] and it was 213 the miRNA with the highest level of promoter hypermethylation (Fig 5B) there is a high-degree of Watson-Crick base-pairing between miRNA and target mRNA at 222 nucleotides 2-7 at the 5' end of miRNA, termed the "seed match" [54] . Mismatches in the miRNA-223 mRNA duplex were found to be ineffective in repressing gene expression [55] . To further 224 delineate the functional role of miR-199b-5p in FECD pathogenesis, we performed in silico 225 analysis to predict putative target genes and corresponding binding sites using two computational 226 prediction algorithms (Targetscan and miRmap). More than one thousand targets of miR-199b-5p 227 were predicted from these programs. Snai1 and ZEB1 were of particular interest because their 228 overexpression leads to excessive extracellular matrix production in FECD [56] . Both prediction 229 tools independently gave Snai1 and ZEB1 high scores (97 and 83.4 respectively). Sequence 230 alignment analyses revealed a highly conserved miRNA-199b-5p binding motif in the 3′-UTR of 231 both Snai1 and ZEB1 across many species (Fig 6A) . In particular, this predicted binding site was 232 located in the 3′-UTR of human Snai1 (positions 725-731; NM_005985.3) and ZEB1 (positions 233 1023-1029; NM_001128128.2) (Fig 6B) . 234
To investigate whether Snai1 and ZEB1 are direct targets of miR-199b-5p and to assess 235 the role of miR-199b-5p in regulating Snai1 and ZEB1 expression in corneal endothelial cells, we 236 cloned human Snai1 and ZEB1 3′-UTR sequences into a luciferase reporter vector (pMIR-Snai1-237
WT and pMIR-ZEB1-WT; Fig 6B, C) . We additionally cloned fragments of human Snai1 and 238 ZEB1 3′-UTR with mutated miR-199b-5p binding sites into a luciferase reporter vector (pMIR-239 SNAI1-Mut and pMIR-ZEB1-Mut; Fig 6B, C) . The reporter plasmids (pMIR-control, pMIR-240 Snai1/ZEB1-WT, and pMIR-Snai1/ZEB1-Mut) were co-transfected into human corneal 241 endothelial cells or HEK293 cells with either miR-199b-5p mimics, miR-199b-5p mimic-negative 242 control, miR-199b-5p inhibitor, or miR-199b-5p inhibitor-negative control, along with a b-243 galactosidase expression plasmid as an internal control. The dual-luciferase reporter assays 244
showed that miR-199b-5p regulated Snai1 and ZEB1 by binding directly to their 3′-UTR 245 sequences. MiR-199b-5p mimics significantly decreased the luciferase activity approximately 50% 246 (p = 0.039) and 30% (p = 0.009), respectively, in cells co-transfected with pMIR-Snai1-WT and 247 pMIR-ZEB1-WT, compared with their corresponding negative controls ( Fig 6C) . In contrast, miR-248 199b-5p inhibitor significantly increased their luciferase activities by 2.1-and 1.5-fold, 249 respectively (P < 0.05; Fig 6C) . However, miR-199b-5p mimic and inhibitor had no effect on 250 luciferase activities in cells co-transfected with pMIR-Snai1-Mut, pMIR-ZEB1-Mut, or empty 251 pMIR-control vectors (P > 0.05; Fig 6C) . Taken together, these data show that miR-199b-5p 252 directly targets the 3′-UTRs of Snai1 and ZEB1 mRNA transcripts. 253
To further evaluate the effect of miR-199b-5p on Snai1 and ZEB1 expression in human 254 corneal endothelial cells, we transfected miR-199b-5p mimic, inhibitor, or negative controls into 255 human corneal endothelial cells and measured the expression levels of Snai1 and ZEB1 by qRT-256 PCR. We found that the miR-199b-5p mimic significantly inhibited Snai1 and ZEB1 expression 257 by 50%, compared to negative control group (P < 0.05; Fig 6D) . In contrast, the miR-199b-5p 258 inhibitor had the opposite effect and resulted in increased Snai1 and ZEB1 expression (~ 1.3 fold, 259 P < 0.05; Fig 6D) . These results demonstrate that miR-199b-5p can directly bind to and negatively 260 regulate Snai1 and ZEB1 in human corneal endothelial cells. 261
262
Discussion
263
FECD is the most common type of corneal endothelial dystrophy and a leading indication for 264 corneal transplantation in patients in the United States [6, 57] . We previously identified global 265 DNA methylation changes that occur in the corneal endothelial tissue of FECD patients and 266 specifically observed a high number of DNA methylation alterations occurring in miRNA 267 sequences [30] . This finding was intriguing because prior reports had demonstrated that miRNAs 268 were differentially expressed in the corneal endothelium during aging [58] , and that widespread 269 downregulation of miRNA levels occurred in the corneal endothelium of patients with late-onset 270 FECD [36, 59] . Because DNA methylation has been shown to be a mechanism for regulating 271 miRNA expression [33], we performed a sub-analysis of the miRNA DNA methylation array data. 272
The most differentially methylated miRNA sequences were further validated by quantitative 273
MethyLight assay using an additional patient cohort. MiR-199B was identified as the most 274 hypermethylated miRNA sequence in FECD and was selected for additional analysis because its 275 expression was almost completely silenced in FECD [36] . In silico analyses identified Snai1 and 276 ZEB1 as potential direct targets of miR-199b-5p. Using a luciferase reporter assay, we confirmed 277 that miR-199b-5p directly targeted the 3′-UTR of both Snai1 and ZEB1 transcripts and negatively 278 regulated their expression. Collectively, these results demonstrate that miR-199b-5p 279 hypermethylation may contribute to late-onset FECD pathogenesis. Our findings suggest that miR-280 199b-5p hypermethylation leads to its down-regulated expression and consequently results in the 281 decreased expression of miR-199b-5p target genes, including Snai1 and ZEB1. 282
MiRNAs are small non-coding RNAs that negatively regulate gene expression by binding 283 to specific sequences in the 3′-UTR of target mRNAs [58, 60] . Such interactions may result in 284 either translation inhibition or induction of mRNA cleavage [60] . Numerous studies have shown 285 that miRNAs are evolutionarily conserved and are key regulators of diverse biological processes 286 such as development, cell proliferation and differentiation, apoptosis and metabolism [61] . 287
MiRNAs also have important regulatory roles in disease progression, including oncogenesis [62, 288 63] . The molecular mechanisms that control miRNA expression are therefore of critical 289 importance in better understanding normal physiologic processes and disease pathogenesis. 290
Recently, DNA methylation has emerged as a key regulatory mechanism of miRNA expression in 291 several different tissues and disease states [62] [63] [64] [65] . 292
In this study, we have demonstrated aberrant DNA methylation of miRNA sequences in 293 corneal endothelial tissue of FECD patients. Our array dataset included 2,227 probes associated 294 with 463 miRNA genes, with multiple probes targeting single miRNA genes. We identified 216 295 probes associated with 156 miRNA genes that were differentially methylated between FECD and 296 control samples, and the vast majority were hypermethylated in FECD. Furthermore, we found 297 that the aberrant DNA methylation occurred almost exclusively in the promoter regions of 298 miRNAs. Since promoter methylation and gene expression are usually inversely correlated, these 299 results suggest DNA hypermethylation as a potential mechanism for the widespread 300 downregulation of miRNA levels in FECD [36] . This preferential hypermethylation of miRNA 301 gene promoters was also reported in other studies [33, [66] [67] [68] . 302
To further investigate the methylated probes in a broader genomic context, we mapped the 303 50bp sequences of all 216 differentially methylation probes associated with 156 miRNA genes to 304 the human genome. We found that approximately three-quarters of these probes were located 305 within introns and/or exons of relevant host genes. The intragenic resident miRNAs on the same 306 strand as their host genes can be co-transcribed by RNA polymerase II and co-regulated with their 307 host genes [69] . A genome-scale DNA methylation analysis specifically on miRNA host genes 308 revealed that miRNA host genes were frequent targets for aberrant DNA methylation and in 309 particular downregulation of miR-10a was correlated with the promoter hypermethylation of its 310 host gene HOXB4 in tumorigenesis [39] . Our data found that the miRNA host genes were 311 differentially methylated in FECD and that their gene body regions were preferential targets of 312 aberrant methylation. Even though gene body methylation is positively correlated with gene 313 expression [70], we were unable to measure the changes in mRNA levels of miRNA host genes 314 on the same sample cohorts used in the DNA methylation analyses because of the low cellular 315 yield. Therefore, the physiological relevance of DNA methylation changes of miRNA host genes 316 in FECD remains to be further explored. Additionally, a subset of miRNA genes and their host 317 genes shared hypermethylation of their individual promoters, suggesting that DNA methylation 318 may play an important role in repressing the expression of certain miRNAs and their host genes 319 simultaneously in FECD. 320
Using two independent DNA methylation assay technologies and two separate patient 321 cohorts, we identified miR-199B as the most hypermethylated miRNA in the FECD samples. 322
Interestingly, miR-199b-5p has been shown to be almost completely silenced in FECD tissues [36] . 323
We were unable to perform side-by-side comparative miRNA transcriptome analysis on the same 324 sample cohorts used in the DNA methylation analyses because of the low cellular yield from the 325 FECD samples. To delineate the mechanism by which miR-199b-5p may contribute to FECD 326 pathogenesis, we used computational algorithms to search for putative target genes, and identified 327 Snai1 and ZEB1 as having high prediction scores. Further functional analyses using a luciferase 328 reporter assay confirmed both 3′-UTRs of Snai1 and ZEB1 transcripts as being direct targets of 329 miR-199b-5p. Our result is consistent with the prior finding that miR-199a-5p, a close family 330 member of miR-199b-5p, directly binds the 3'-UTR of the Snai1 mRNA and reduces Snai1 protein 331 level via the UGUGACC motif in its seed sequence [71] . Members of the same miRNA family 332
can have similar physiological function and share the same predicted targets because of their 333 conserved sequence and structural configuration [72] . Our finding that the 3'-UTRs of Snai1 and 334 ZEB1 have the same predicted target site recognized by the identical seed sequence for both miR-335 199a-5p and miR-199b-5p supports the miR-199 family as having an important regulatory role in 336 Snai1 and ZEB1 expression and function. 337 MethyLight reactions is provided in Supplementary Table S1 . 397 398
Construction of the luciferase reporter plasmids 399
The putative binding sites in the 3′-UTRs of Snai1 and ZEB1 genes were bioinformatically 400 predicted for miR-199b-5p using multiple computational prediction algorithms, including 401 TargetScan 
Statistical analyses 464
Statistical analyses on genome-wide methylation data of miRNA genes were executed in R [30] . 465
All other analyses were performed using two-tailed t-tests to compare mean values using R 466 The location of Illumina Infinium HM450 array probes used in MethyLight reactions for miR -791 199A1, miR-874, miR-140, miR-23B and miR-1306 MiRNAs and host genes were co-methylated at corresponding promoter regions in FECD. 819
MiR-199B is the most hypermethylation miRNA genes in FECD. Its mature transcript miR-199b-865 5p functions as a direct negative regulatior of two zinc finger transcription factors, Snai1 and ZEB1, 866 which have been shown to lead to increased production of extracellular matrix proteins in FECD. 867 868 
